Health ❯ Healthcare ❯ Patient Advocacy

Rare Diseases

Awareness Campaigns Hypothalamic Obesity Niemann-Pick Disease Individualized Therapies

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

The decision follows a late-stage study that showed a 15.8% BMI reduction at 52 weeks compared with a 2.6% increase on placebo.